Federal Analogue Act

Federal Analogue Act

Other short titles	Alcohol and Drug Abuse Amendments of 1986 Anti-Drug Abuse Act of 1986
Long title	An Act to strengthen Federal efforts to encourage foreign cooperation in eradicating illicit drug crops and in halting international drug traffic, to improve enforcement of Federal drug laws and enhance interdiction of illicit drug shipments, to provide strong Federal leadership in establishing effective drug abuse prevention and education programs, to expand Federal support for drug abuse treatment and rehabilitation efforts, and for other purposes.
Nicknames	Controlled Substance Analogue Enforcement Act of 1986
Enacted by	the 99th United States Congress
Effective	October 27, 1986
Citations
Public law	99-570
Statutes at Large	100 Stat. 3207 aka 100 Stat. 3207-13
Legislative history
Introduced in the House as H.R. 5484 by James C. Wright Jr. (D–TX) on September 8, 1986 Committee consideration by House Armed Services, House Banking, Finance, and Urban Affairs, House Education and Labor, House Foreign Affairs, House Government Operations, House Energy and Commerce, House Interior and Insular Affairs, House Judiciary, House Merchant Marine and Fisheries, House Post Office and Civil Service, House Public Works and Transportation, House Ways and Means Passed the House on September 11, 1986 (392-16) Passed the Senate on September 30, 1986 (97-2, in lieu of S. 2878) with amendment House agreed to Senate amendment on October 17, 1986 (unanimous consent) with further amendment Senate agreed to House amendment on October 17, 1986 (voice vote) Signed into law by President Ronald Reagan on October 27, 1986

The Federal Analogue Act, 21 U.S.C. § 813, is a section of the United States Controlled Substances Act passed in 1986 which allowed any chemical "substantially similar" to a controlled substance listed in Schedule I or II to be treated as if it were also listed in those schedules, but only if intended for human consumption. These similar substances are often called designer drugs.

21 U.S.C. § 802(32)

United States v. Forbes, 806 F. Supp. 232 (D. Colo. 1992), a Colorado district court case, considered the question of whether the drug alphaethyltryptamine (AET) was a controlled substance analogue in the USA. The controlled drugs to which it was alleged that AET was substantially similar were the tryptamine analogues dimethyltryptamine (DMT) and diethyltryptamine (DET).

AET

DMT

...
Wikipedia